Analgesic effects of flecainide on postherpetic neuralgia.

Sodium channel blockers have been reported to be effective in relieving neuropathic pain. However, although intravenous lidocaine has proved to be effective, in some patients oral mexiletine fails to produce adequate pain relief. In this study, we investigated the analgesic effect of flecainide, a long-lasting antitachyarrhythmic drug, on postherpetic neuralgia. Twenty patients with postherpetic neuralgia received an intravenous infusion of flecainide and 15 (75%) of those who achieved pain relief subsequently received oral flecainide. The patients were assessed using a 100 mm visual analog scale 1 month after treatment. Significant improvement compared with the pretreatment reading was found. This study suggests that the action of flecainide in blocking the sodium channel is potent and long-lasting and that, like the intravenous formulation, the oral formulation has a stable analgesic effect on postherpetic neuralgia.
AuthorsM Ichimata, H Ikebe, S Yoshitake, S Hattori, H Iwasaka, T Noguchi
JournalInternational journal of clinical pharmacology research (Int J Clin Pharmacol Res) Vol. 21 Issue 1 Pg. 15-9 ( 2001) ISSN: 0251-1649 [Print] Switzerland
PMID11708571 (Publication Type: Journal Article)
Chemical References
  • Analgesics, Non-Narcotic
  • Sodium Channel Blockers
  • Flecainide
  • Aged
  • Aged, 80 and over
  • Analgesics, Non-Narcotic (administration & dosage, adverse effects, therapeutic use)
  • Female
  • Flecainide (administration & dosage, adverse effects, therapeutic use)
  • Herpes Zoster (complications)
  • Humans
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Neuralgia (drug therapy, etiology)
  • Sodium Channel Blockers

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: